Found: 9
Select item for more details and to access through your institution.
Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0265189
- By:
- Publication type:
- Article
Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn's disease.
- Published in:
- Cell & Tissue Research, 2018, v. 374, n. 2, p. 339, doi. 10.1007/s00441-018-2860-8
- By:
- Publication type:
- Article
Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 10, p. 1301, doi. 10.1111/apt.15227
- By:
- Publication type:
- Article
Deep learning‐based image analysis reveals significant differences in the number and distribution of mucosal CD3 and γδ T cells between Crohn's disease and ulcerative colitis.
- Published in:
- Journal of Pathology: Clinical Research, 2023, v. 9, n. 1, p. 18, doi. 10.1002/cjp2.301
- By:
- Publication type:
- Article
Ulcer‐associated cell lineage expresses genes involved in regeneration and is hallmarked by high neutrophil gelatinase‐associated lipocalin (NGAL) levels.
- Published in:
- Journal of Pathology, 2019, v. 248, n. 3, p. 316, doi. 10.1002/path.5258
- By:
- Publication type:
- Article
Establishment of a Patient-Derived Xenograft Model of Colorectal Cancer in CIEA NOG Mice and Exploring Smartfish Liquid Diet as a Source of Omega-3 Fatty Acids.
- Published in:
- Biomedicines, 2021, v. 9, n. 3, p. 282, doi. 10.3390/biomedicines9030282
- By:
- Publication type:
- Article
Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2318, doi. 10.3390/cancers15082318
- By:
- Publication type:
- Article
Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 10, p. 914, doi. 10.1007/s00535-021-01814-y
- By:
- Publication type:
- Article
The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry.
- Published in:
- Hereditary Cancer in Clinical Practice, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1897-4287-12-12
- By:
- Publication type:
- Article